Does MOLSIDOMINE Cause Ocular hyperaemia? 10 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Ocular hyperaemia have been filed in association with MOLSIDOMINE. This represents 2.6% of all adverse event reports for MOLSIDOMINE.
10
Reports of Ocular hyperaemia with MOLSIDOMINE
2.6%
of all MOLSIDOMINE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Ocular hyperaemia From MOLSIDOMINE?
Of the 10 reports, 10 (100.0%) required hospitalization.
Is Ocular hyperaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLSIDOMINE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does MOLSIDOMINE Cause?
Toxic epidermal necrolysis (84)
Blister (54)
Erythema (53)
Nausea (48)
Multiple organ dysfunction syndrome (45)
Respiratory disorder (44)
Diarrhoea (41)
Hypertension (37)
Cholecystitis (36)
Electrolyte imbalance (36)
What Other Drugs Cause Ocular hyperaemia?
DUPILUMAB (6,938)
CYCLOSPORINE (1,508)
BIMATOPROST (1,447)
CENEGERMIN-BKBJ (1,226)
BRIMONIDINE (917)
ADALIMUMAB (714)
LATANOPROST (587)
DORZOLAMIDE\TIMOLOL (581)
LIFITEGRAST (570)
TRAVOPROST (478)
Which MOLSIDOMINE Alternatives Have Lower Ocular hyperaemia Risk?
MOLSIDOMINE vs MOMELOTINIB
MOLSIDOMINE vs MOMETASONE
MOLSIDOMINE vs MOMETASONE FUROATE
MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE
MOLSIDOMINE vs MONOMETHYL